Enochian Biosciences Inc ENOB Income Statement

Enochian biosciences inc (ENOB)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenues
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	0	42	0	-	0	0	0	0	0	0	0	0	31	0	0	0	0	0	0	0	0
Cost of Goods Sold
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	5	0	21	44	70	143	64	17	40	16	36	15	-	-	-	-	-	-	-	-
Gross profit (Loss)
-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	37	0	-21	-44	-70	-143	-64	-17	-40	-15	-36	16	-	-	-	-	-	-	-	-
Operating Expenses
General and administrative
1,486	2,235	1,868	1,487	1,951	3,580	1,251	963	1,979	668	288	211	168	348	204	445	257	321	204	366	372	656	240	421	326	8	264	138	175	9	7	11	4	11	14	0	8
Stock-Based Compensation Expense
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Cash and Stock-Based Compensation Expense
-	-	-	-	-	-	-	-	-	-	-112	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Cash and Stock-Based Compensation Expense
-	-	-	-	-	-	-	-	-	-	-	0	0	0	626	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
2,307	561	520	485	730	788	493	105	137	219	153	15	16	13	17	188	235	277	101	1,473	151	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and Amortization
-	-	-	-	-	-	-	-	761	3	3	-	3	3	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
35	21	21	50	3	12	5	-	-	-	-	-	-	-	-	3	3	15	3	3	4	4	4	2	6	18	1	10	8	-	-	-	-	-	-	-	-
Consulting Expenses
-	-	31	-	-	-	62	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consulting Expenses
-	-	-	-	-	-	-	-21	359	388	67	417	162	182	0	32	16	16	30	3	291	203	125	79	61	262	58	56	13	-	-	-	-	-	-	-	-
Total Operating Expense
3,829	2,818	2,442	2,110	2,685	4,381	1,812	183	3,238	1,281	625	648	351	548	852	671	513	632	341	1,847	820	865	370	503	394	935	323	205	196	-	-	-	-	-	-	-	-
LOSS FROM OPERATIONS
-3,829	-2,818	-2,442	-2,110	-2,685	-4,381	-1,812	-183	-3,238	-1,281	-625	-648	-351	-548	-852	-670	-513	-594	-341	-1,869	-865	-935	-513	-568	-412	-976	-339	-242	-180	-	-	-	-	-	-	-	-
Other Income (Expense)
Change in fair value of contingent consideration
2,310	1,082	-1,942	3,268	-217	-11,593	1,468	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-12	-	-	-	-0	-0	-0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Income (Expense)
-	-	-	-	-	-	-	-	-1	-0	0	5	2	2	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-0	0	-	-	16	19	34	13	0	220	165	159	0	0	0	-	0	0	-	-
Interest (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-28	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Income (Expense) - Related Party
-	-	-	-	-	-	-	-	-183	12	0	4	3	3	3	0	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on forgiveness of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	48	0	-	-	-	-	-	-	-	-	-
(Loss) gain on currency transactions
-0	-137	286	11	164	-169	-31	-393	87	209	387	475	96	-376	23	-148	272	-166	-32	76	-392	-40	0	0	0	10	90	18	-100	-	-	-	-	-	-	-	-
Gain on settlement
5	135	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income
12	18	14	-	8	36	26	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Income, Forgiveness of Debt
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	39	49	45	41	-	-	-	-	-	-	-	-
Gain on Sale of Assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-
Interest and Other Income
-	-	-	-	-	-	-	-	1	6	8	0	0	0	0	0	0	0	0	-6	6	5	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-
Total Other Income (Expense)
2,315	1,097	-1,640	3,280	-44	-11,725	1,462	-1,966	273	202	395	465	90	-382	18	-149	272	-166	-32	75	-387	-64	-19	-21	-13	-	-	-	-	-	-	-	-	-	-	-	-
Loss Before Income Taxes
-1,514	-1,720	-4,083	1,170	-2,730	-16,107	-350	-2,149	-2,964	-1,078	-230	-182	-260	-931	-833	-	-	-	-	-	-	-	-	-	-	-8	-	-	-9	-9	-7	-11	-4	-11	-14	-0	-8
Total Other Income (Expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-34	-	-	-32	-101	-218	-	-	-	-	-	-	-	-
(Loss) Before Income Taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-241	-761	-374	-1,793	-1,253	-999	-533	-602	-426	-8	-371	-343	-399	-9	-7	-11	-	-11	-14	-	-
Income Tax Benefit
-	-	0	-	-	-	0	-100	-4	-1	-4	2	-14	-12	-40	-64	-33	-340	-23	-373	0	-46	2	-132	0	0	0	0	0	0	0	0	0	0	0	0	0
LESS NET LOSS ATTRIBUTABLE TO NON-CONTROLLED INTEREST IN SUBSIDIARY
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
NET LOSS
-1,514	-1,720	-4,083	1,170	-2,730	-16,107	-350	-2,049	-2,960	-1,076	-225	-184	-246	-918	-793	-755	-207	-421	-350	-1,420	-1,253	-953	-535	-456	-426	-8	-371	-	-399	-9	-7	-11	-4	-11	-14	-0	-8
NET (LOSS)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-469	-	-	-	-343	-399	-	-	-	-	-	-	-	-
BASIC AND DILUTED LOSS PER SHARE
-0.03	-0.04	-0.09	0.05	-0.07	-0.45	-0.01	-0.07	-0.12	-0.08	-0.02	0.04	-0.03	-0.10	-0.08	-0.08	-0.02	-0.04	-0.04	-0.15	-0.13	-0.11	-0.07	-0.06	-0.06	0.00	-0.07	-0.06	-0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED
46,275	46,275	46,241	40,794	37,070	36,172	36,170	36,438	24,790	13,847	12,685	20,465	9,533	9,533	9,533	9,533	9,533	9,533	9,533	9,533	9,533	8,925	8,080	8,040	6,880	5,000	5,318	5,318	5,133	5,000	5,000	5,000	5,015	5,000	2,826	0	0